Article Details

With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers

Retrieved on: 2021-04-06 20:37:07

Tags for this article:

Click the tags to see associated articles and topics

With $44M and Microsoft R&D alliance, Volastra takes aim at metastatic cancers. View article details on hiswai:

Excerpt

Volastra was founded by Polaris Partners, which provided its initial $12 million seed financing last year. The startup's science is based on the research ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up